MDXL OTC
Medixall Group, Inc.
1W: +0.0%
1M: -5.7%
3M: -41.1%
YTD: +3200.0%
1Y: +3200.0%
3Y: -98.1%
5Y: -99.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$309K
+422.1% ▲
5Y CAGR: +178.2%
Gross Profit
$73K
+102.3% ▲
Operating Income
-$4M
+40.1% ▲
Net Income
-$5M
+33.2% ▲
EPS (Diluted)
$-0.04
+38.9% ▲
EBITDA
-$4M
+40.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $3K | $0 | $15K | $59K | $309K |
| YoY Growth | +44.5% | -100.0% | +0.0% | +295.3% | +422.1% |
| Cost of Revenue | $1M | $3M | $3M | $3M | $237K |
| Gross Profit | -$1M | -$3M | -$3M | -$3M | $73K |
| Gross Margin | -51065.2% | — | -20349.5% | -5296.2% | 23.6% |
| R&D Expenses | $0 | $0 | $0 | $39K | $0 |
| SG&A Expenses | $3M | $5M | $6M | $6M | $4M |
| Operating Expenses | $3M | $6M | $6M | $59K | $4M |
| Operating Income | -$3M | -$6M | -$7M | -$7M | -$4M |
| Operating Margin | -127409.7% | — | -43561.3% | -11035.2% | -1265.6% |
| Interest Expense | $0 | $0 | $0 | $271K | $647K |
| Income Before Tax | -$3M | -$6M | -$6M | -$7M | -$5M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$3M | -$6M | -$6M | -$7M | -$5M |
| Net Margin | -127409.7% | — | -40245.8% | -11524.6% | -1474.8% |
| EPS (Diluted) | $-0.05 | $-0.07 | $-0.06 | $-0.06 | $-0.04 |
| EBITDA | -$3M | -$6M | -$6M | -$7M | -$4M |
| Shares Outstanding | 74M | 91M | 104M | 117M | 127M |